Leveraging a QSP Platform for Prediction of Clinical Efficacy and Safety Biomarkers in Immuno‐Oncology Combination Therapy
Clinical Pharmacology & Therapeutics · 2026
DOI: 10.1002/cpt.70515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2026. Verfasst von Daniela Santurio und 10 weiteren Autor:innen. Beteiligte Einrichtung: Certara UK, Sheffield, UK. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Antineoplastic Combined Chemotherapy Protocols, Network Pharmacology, Computer Simulation. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
IO Simulator is a Quantitative Systems Pharmacology platform implementing a mechanistic model of solid tumor–immune system interactions and the action of standard immuno‐oncology drugs. Using a tarlatamab case study, we demonstrate how IO Simulator predicts combination therapy efficacy and cytokine biomarkers, which can be statistically related to the risk of cytokine release syndrome (CRS). This allows patient stratification and identification of doses that maximize efficacy without a substantial increase in cytokine release.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Certara UK, Sheffield, UK.
- Merck & Co., Inc., Rahway, New Jersey, USA.
- University of Leiden, Leiden, The Netherlands.
- School of Biosciences, University of Surrey, Guildford, UK.
Zitieren
APA
Santurio, D., Yonucu, S., Alam-Nazki, A., Debir, B., Swat, M., Rose, R. H., Sorribes, I. C., Zhao, M., Freshwater, T., van der Graaf, P. H., & Kierzek, A. M. (2026). Leveraging a QSP Platform for Prediction of Clinical Efficacy and Safety Biomarkers in Immuno‐Oncology Combination Therapy. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70515
Vancouver
Santurio D, Yonucu S, Alam-Nazki A, Debir B, Swat M, Rose RH, et al. Leveraging a QSP Platform for Prediction of Clinical Efficacy and Safety Biomarkers in Immuno‐Oncology Combination Therapy. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70515
BibTeX
@article{Santurio2026,
author = {Santurio, Daniela and Yonucu, Sirin and Alam-Nazki, Aiman and Debir, Birses and Swat, Maciej and Rose, Rachel H and Sorribes, Inmaculada C and Zhao, Miao and Freshwater, Tomoko and van der Graaf, Piet H and Kierzek, Andrzej M},
title = {Leveraging a QSP Platform for Prediction of Clinical Efficacy and Safety Biomarkers in Immuno‐Oncology Combination Therapy},
journal = {Clinical Pharmacology & Therapeutics},
year = {2026},
doi = {10.1002/cpt.70515}
}
EUVIMED